spacer
home > epc > Autumn 2009
PUBLICATIONS

European Pharmaceutical Contractor

epc
Autumn 2009

European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.

   
Text
PDF
bullet
Marketplace & Business
Following the recent publication of the long-awaited European Commission Final Report on its enquiry into the pharmaceutical sector, Catriona Hatton, Suzanne Rab, Jean-Michel Coumes and David Cardwell at Hogan and Hartson outline its key findings and implications for the industry.  
view
Claudio A Lorck and Arnim Laicher at Temmler Weker GmbH investigate how current economic conditions in the pharmaceutical industry are affecting the outsourcing market, and review the most effective tactical and strategic approaches to outsourcing wisely.  
view
download pdf
bullet
Legal & Regulatory
Helen Brooker at Cognitive Drug Research (CDR) Ltd considers how clinical studies working in neurodegenerative diseases can be improved in the light of new EMEA guidelines for companies developing medicines for the treatment of Alzheimer's disease, other dementias and Parkinson's disease.  
view
download pdf
Alejandro Arana and Félix Arellano of Risk MR Pharmacovigilance Services and Teresa Cuchí Actiomed look at the progression of pharmacovigilance in the EU, and assess the likely impact of recent proposals for new Europe-wide legislation.  
view
download pdf
bullet
Clinical Development
Changes in the global economy over the last decade have had a dramatic impact on biotech and pharma companies, but central laboratories can play a key role in mitigating the impact of financial pressure, says Hermann Schulz at INTERLAB central lab services - worldwide GmbH.  
view
download pdf
Oleg Tikhonov, Natalia Ukolova and Platon Komissarov at Synergy Research Group discuss the advantages of regional sites - as opposed to the major cities of Moscow and St Petersburg - when recruiting patients for clinical trials in Russia, and offer some invaluable advice.  
view
download pdf
The data monitoring committee (DMC) has an important role to play in upholding ethical standards and ensuring that the objectives of a clinical trial are reasonable; however its role is not always fully valued. Ronald Kershner at AAIPharma, Inc suggests ways in which the function of a DMC can be optimised.  
view
download pdf
bullet
DRUG DISCOVERY, DELIVERY & THERAPEUTICS
The reduction of animal testing is not just a matter of ethical concern but also of better scientific practice. Nirmala Bhogal, Rita Seabra and Michelle Hudson at FRAME explore methodological approaches which can limit the use of animals in clinical research.  
view
download pdf

Continuing the theme of reducing animal testing, Peter Ertl and Lukas Richter at the Austrian Institute of Technology ask why so many drugs fail despite initial successful animal testing, and examine the alternative of developing 3D cell culture on chip.

 
view
download pdf
David Ward at Melbourn Scientific explains why close integration between formulation, analysis and manufacture can help to identify potential problems as early as possible in the development process, reducing the likelihood of costly and time-consuming failures.  
view
download pdf
bullet
CDISC & Electronic Data Capture
Joris De Bondt at SGS Life Sciences discusses the benefits of Clinical Data Acquisition Standards Harmonization (CDASH) - one particular standard in the CDISC portfolio whose benefits are already being felt in EDC trials.  
view
download pdf
The integration of clinical research with healthcare has recently been a hot topic in the world of EDC. Jozef Aerts at XML4Pharma reviews the current situation, the regulatory issues, and hurdles for real-life implementation.  
view
download pdf
Mats Sundgren at AstraZeneca, Petra Wilson at Cisco, and independent consultant Isabelle de Zegher discuss the importance of electronic health records, explaining why failing to adopt their systematic use could have serious consequences for the EU.  
view
download pdf
The adoption of technology to enable CDISC standards paves the way to considerable benefits for CROs. Despite this, some organisations have been notably slow to react. Dave Smith at SAS UK considers the reasons why.  
view
download pdf
Barbara Rapchak at Leap of Faith Technologies, Inc describes how the latest telemonitoring technology can make a huge difference to quality of life for cancer patients, and support clinical research by improving compliance.  
view
download pdf
bullet
LABS & Logistics
Ken Lukes at Inmark argues that the increasingly multinational landscape in which businesses now operate has made harmonisation of temperature-controlled packaging systems more important than ever, and offers advice in achieving this objective.  
view
download pdf
The worldwide nature of clinical trials poses a considerable challenge to biotech and pharmaceutical companies, who are obliged to transport a wide variety of temperature-sensitive materials over vast distance and variable climatic conditions. Jeff Clark of BioStorage Technologies lays out the ground rules for effective cold chain logistics.  
view
download pdf
bullet
ECG CORE LABS & CARDIAC SAFETY
J Rick Turner of Quintiles ECG Services looks at the central importance of the ICH E14 thorough QT/QTc study in drug safety and evaluation, and gives insight into its design, methodology and interpretation.  
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Successfully managing the unique demands of cell therapy supply chains

PCI Pharma Services

Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >>

Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement